36 results
Thumbnail

D1.233 - Pembrolizumab IgE mediated drug hypersensitivity reaction and successful desensitisation

Thumbnail

D1.234 - The Importance of Differential Diagnosis in DRESS Syndrome: Review of 2 Cases

Thumbnail

D1.235 - Clorhexidine allergy in northern area of Seville

Thumbnail

D1.236 - Clinical Outcomes of Neuromuscular Blocking Agent Rechallenge Based on Skin Prick Test in Patients with Intraoperative Anaphylaxis

Thumbnail

D1.237 - What Do Drug Skin Tests Tell Us About Quinolone Allergy? Adult Allergy Reference Center Experience

Thumbnail

D1.238 - Urgent desensitization to amiodarone

Thumbnail

D1.239 - Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels

Thumbnail

D1.243 - L-asparaginase desensitization in children

Thumbnail

D1.244 - Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media: Experience in 165 Patients

Thumbnail

D1.245 - Platinum salt hypersensitivity: Experience of our Center

Thumbnail

D1.246 - Cephalosporin Allergy in Children

Thumbnail

D1.247 - Tolerance to intravenous sodium heparin despite a positive subcutaneous challenge test: A case report

Thumbnail

D3.48 - The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital

Thumbnail

D3.53 - A retrospective audit of NSAID hypersensitivity in children and young people in a tertiary paediatric allergy centre

Thumbnail

D3.55 - Synthetic folic acid allergy

Thumbnail

D3.47 - Implementing Penicillin Delabelling in an Inpatient setting

Thumbnail

D3.49 - Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study

Thumbnail

D3.50 - Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists

Thumbnail

D3.51 - Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists

Thumbnail

D3.54 - Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?